Cited by 142Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET

Van Laere, Koen, Goffin, Karolien, Casteels, Cindy, Dupont, Patrick, Mortelmans, Luc, de Hoon, Jan, Bormans, Guy·2008·NeuroImage

DOI 10.1016/j.neuroimage.2007.10.053

Open this paper in CoChat — free account

Abstract

The endocannabinoid system (ECS) is implicated as a regulator of homeostasis of several cerebral functions and is a novel target for drug treatment of neuropyschiatric disorders. So far, the cerebral cannabinoid-type 1 receptor (CB1R) has only been studied using in vitro, animal model, electrophysiological and post-mortem data. We have used positron emission tomography (PET) using a high-affinity, subtype-selective radioligand, [(18)F]MK-9470, to assess the in vivo cerebral CB1R distribution and its variation with healthy aging and gender. Fifty healthy volunteers (25 M/25 F, 18-69 years) underwent [(18)F]MK-9470 PET. Parametric [(18)F]MK-9470 binding maps were constructed, corrected for partial volume effects and analyzed using statistical parametric mapping in a combined categorical (gender) and covariate (age) design. We found that [(18)F]MK-9470 binding to CB1R increased with aging but only in women (p(FWE)<0.05, corrected for multiple comparisons); this was most pronounced in the basal ganglia, lateral temporal cortex and limbic system, especially in the hippocampus. Men showed higher [(18)F]MK-9470 binding then women (p<0.001, uncorrected), in clusters of the limbic system and cortico-striato-thalamic-cortical circuit. Region-dependent and gender-related upregulation of [(18)F]MK-9470 binding with aging is in line with ex vivo findings in rodent studies and may be associated with a changing homeostatic capacity or compensation mechanisms in the ECS that is modulated by sex hormones. In vivo PET of the CB1R will likely improve our understanding of the ECS in several neurological and psychiatric disorders.

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2007.10.053

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,280
Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients
Pi-Sunyer, X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & for the RIO-North America Study Group (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,227
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052

Show all 53 references

Sorted by citations

Items 101–142 of 142

The historical progression of positron emission tomography research in neuroendocrinology
Bini, J. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101081 · Cited by 6
Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry
Kasvis, P., Canac‐Marquis, M., Aprikian, S., Vigano, M., & Vigano, A. A. L. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07193-1 · Cited by 6
Ageing, Neurodegeneration and the Endocannabinoid System
Fernández‐Ruíz, J., Sagredo, O., Gómez‐Ruíz, M., & de Lago, E. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_597 · Cited by 5
PET Imaging of the Endocannabinoid System
Terry, G. E., Raymont, V., & Horti, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_12 · Cited by 5
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
Blebea, N. M., Pușcașu, C., Hancu, G., Stăniguț, A. M., & Chiriță, C. (2025) · Pharmaceuticals · doi:10.3390/ph18060890 · Cited by 5
Lifespan changes in cannabinoid 1 receptor mRNA expression in the female C57BL/6J mouse brain
Li, X., Zhao, G., Huang, H., Ye, J., Xu, J., Zhou, Y., Zhu, X., Wang, L., & Wang, F. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25427 · Cited by 4
Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology
Bailey, C. R., & Neumeister, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.011 · Cited by 4
Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort
Minhas, M., & Lunn, S. E. (2023) · Journal of Cannabis Research · doi:10.1186/s42238-023-00192-x · Cited by 4
The role of the endocannabinoid system in the pathogenesis and treatment of epilepsy
Kosenkov, A. M., Mal’tseva, V. N., Maiorov, S. A., & Gaidin, S. G. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0114 · Cited by 4
Maternal obesity changes the small intestine endocannabinoid system and fecal metabolites of weanling rats associated with reduced intestinal permeability and impaired glucose homeostasis
de Almeida, M. M., Calviño, C., Reis-Gomes, C. F., Lombardi, I., Brand, A. L. M., Pazos-Moura, C. C., Garrett, R., Alves, M. A., & Trevenzoli, I. H. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109802 · Cited by 4
Acute stress induces different changes on the expression of CB1 receptors in the hippocampus of two lines of male rats differing in their response to stressors
Serra, M. P., Boi, M., Lai, Y., Trucas, M., Fernández‐Teruel, A., Corda, M. G., Giorgi, O., & Quartu, M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173901 · Cited by 3
Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [18F]FMPEP-d2 and [18F]MAGL-2102
Pees, A., Morrone, C. D., Tong, J., Rong, J., Shao, T., Wear, D., Liang, S. H., Yu, W. H., & Vasdev, N. (2025) · Theranostics · doi:10.7150/thno.106592 · Cited by 3
Prevalence and correlates of cannabis abuse among residents in the community of Fort McMurray, a city in Northern Alberta which had endured multiple natural disasters
Obuobi-Donkor, G., Eboreime, E., Shalaby, R., Agyapong, B., & Agyapong, V. I. O. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.962169 · Cited by 3
Chronic Administration of Δ 9 -Tetrahydrocannabinol Alters Brain Glucose Uptake and Improves Waiting Impulsivity in the Rat
Miederer, I., Schmitt, U., Bausbacher, N., Röhrich, J., Mildenberger, P. C., Lutz, B., Tüscher, O., & Schreckenberger, M. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0268 · Cited by 3
Physiology of the endocannabinoid system: Imaging and the use of positron emission tomography (PET)
Poluga, C., Varlow, C., Vasdev, N., Boileau, I., & Best, L. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00011-5 · Cited by 3
Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type‐1 receptors
Ahamed, M., Verbruggen, A., & Bormans, G. M. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3017 · Cited by 3
Self-citation
In vivo imaging of the cannabinoid CB1 receptor using positron emission tomography
Terry, G. E. (2009) · Figshare · Cited by 3
In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse
Máthé, D., Horváth, I., Szigeti, K., Donohue, S. R., Pike, V. W., Jia, Z., Ledent, C. A., Palkovits, M., Freund, T. F., Halldin, C., et al. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.01.001 · Cited by 2
Brain PET Imaging in the Cannabinoid System
Wong, D. F., Nandi, A., Zaidi, E., Gean, E. G., Horti, A. G., Фролов, Б. А., George, N., & Brašić, J. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00002-6 · Cited by 2
Brain Imaging of Cannabinoid Receptors
Casteels, C., Bormans, G. M., & Laere, K. V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00003-8 · Cited by 2
Self-citation
Correlation analysis of positron emission tomography/computed tomography-magnetic resonance imaging of cannabinoid type 1 receptor in the lumbar spine and brain of aged osteoporosis female cynomolgus monkeys
Hou, L., Zhang, H., Li, Y., Zhu, H., Liao, K., Guo, B., Dong, C., Li, G., Ye, W., Wang, L., et al. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-118 · Cited by 2
Cannabis Use in Older Individuals May Be an Important and Under-Recognized Risk Factor for Motor Vehicle Crashes
Pearlson, G. D., D'Souza, D., Marottoli, R. A., & Stevens, M. C. G. (2025) · Cannabis and Cannabinoid Research · doi:10.1177/25785125251410814 · Cited by 1
Cannabinoid type 1 receptor availability imaging in attention-deficit/hyperactivity disorder using [18F]MK-9470 positron emission tomography: study protocol of the CB1-ADHD study
Miederer, I., Schofer, M. L., Ruckes, C., Retz, W., Schreckenberger, M., & Sebastian, A. (2026) · EJNMMI Reports · doi:10.1186/s41824-026-00322-7 · Cited by 1
Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function
Gorzalka, B. B., & Dang, S. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_8 · Cited by 1
Brain PET Poster Sessions PP01-M01 to PP02-N07
Lange, D., Tejada, I. M., xiong, M., Hillebrand, B., Noergaard, M., Baerentzen, S., Shalgunov, V., Herth, M. M., Svarer, C., & Palner, M. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19851018 · Cited by 1
Examining Neuropsychological Sex Differences in Young Adult Cannabis Users
Crane, N. A. (2013) · Figshare
Developing Targeted PET Tracers in the Era of Personalized Medicine
Bohorquez, S. M. S., van Bruggen, N., & Mařı́k, J. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677252.ch12
Imaging and Quantitation of Cannabinoid CB 1 Receptors in Human and Monkey Brains
Terry, G. E., Hirvonen, J., Liow, J., Zoghbi, S. S., Gladding, R. L., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., Morse, C. L., et al. (2010)
Comparison of Cannabinoid CB 1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography
Verdurand, M., Nguyen, V. H., Stark, D., Zahra, D., Grégoire, M., Greguric, I. D., & Zavitsanou, K. (2011)
Cerebral cannabinoid-1 receptor availability in functional dyspepsia: a [18F]MK-9470 PET study
Ly, H. G., Ceccarini, J., Weltens, N., Bormans, G. M., Laere, K. V., Tack, J. F., & Oudenhove, L. V. (2014) · Lirias (KU Leuven)
Self-citation
Investigating Nutritional Status in Moderate to Severe Alzheimer's Disease Patients Enrolled in a Randomized Controlled Trial with Nabilone
Sherman, C. (2018) · TSpace (University of Toronto)
Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Human and Rat Spinal Cord Tissue
Parnell, J. (2022) · doi:10.22215/etd/2022-15303
Retraction: Alteration of the Endocannabinoid System in Human Alzheimer’s Disease Brain
USURJ Team (2024) · USURJ University of Saskatchewan Undergraduate Research Journal · doi:10.32396/usurj.v9i2.659
Cannabis smoke and oral Δ9THC enhance working memory in aged but not young adult subjectsPreprint
Zequeira, S., Gazarov, E. A., Güvenli, A. A., Berthold, E. C., Senetra, A. S., Febo, M., Hiranita, T., McMahon, L. R., Sharma, A., McCurdy, C. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.26.615028
A Preliminary Investigation of Brain Cannabinoid Receptor Type 1 (CB1R) Availability in Men with Opioid Use DisorderPreprint
Nia, A. B., Aghaei, A. M., Weleff, J., Shi, J. M., Contreras, A., Griffin, M., Jegede, O. O., Pittman, B. P., Harpaz‐Rotem, I., Hillmer, A. T., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7715611/v1
Cannabinoid modulation of behavioral processes : from adolescence to adulthood
Ioannidou, C. (2021) · theses.fr (ABES) · doi:10.70675/85fe2023za70dz4d65z83c9z9828ec89522f
Sex and Gender Differences in Cannabis Use Disorder
Mostallino, R., & Fattore, L. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_12
The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis
Laurikainen, H., Armio, R.-L., Tuominen, L. J., Nyman, M. J., Kirjavainen, A. K., Rajander, J., Haaparanta‐Solin, M., Solin, O. H., & Hietala, J. A. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbag038
Sex- and APOE ε4-dependent expression patterns of the Cannabinoid Receptor-1, FAAH, and MAGL are weakened in late-onset Alzheimer disease frontocortical samplesPreprint
Heistad, R. M., Nyarko, J. N. K., Pennington, P. R., Saeed, H., Gomes, L. V. B., & Mousseau, D. D. (2026) · Research Square · doi:10.21203/rs.3.rs-9717404/v1
Increased Cannabinoid Receptor 1-Immunopositive Perisomatic Input of Principal Cells in Human Epileptic Patients in Focal Cortical Dysplasia Type IIB
Szekeres‐Paraczky, C., Szocsics, P., Erőss, L., Mihály, O. S., & Maglóczky, Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146326
Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis
Sorkhou, M., Kim, H. K., Farzan, F., Foster, J. A., Frey, B. N., Husain, M. I., Kennedy, S. H., Lam, R. W. M., Milev, R. V., Mulsant, B. H., et al. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02362-3
The endocannabinoid system and the ageing brain
Zimmer, A. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01085-7

Authors: Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., & Bormans, G.
Affiliations: Universitair Ziekenhuis Leuven (BE)
KU Leuven (BE)
ORCID: Goffin, Karolien
Casteels, Cindy
Dupont, Patrick
Bormans, Guy
Venue: NeuroImage
Publisher: Elsevier BV
Published: 2008-02
Volume: 39
Issue: 4
Pages: 1533-1541
ISSN: 1053-8119 (ISSN-L)
DOI: 10.1016/j.neuroimage.2007.10.053
OpenAlex: W2088851718
Cited by: 142
References: 53
Citations by year: 2026: 7 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 14 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 11 · 2013: 11 · 2012: 6
FWCI: 3.72
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: NeuroImage (publishedVersion)
PubMed (publishedVersion)
Lirias (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: cannabinoid type 1 receptor, CB1R, endocannabinoid system, healthy aging, sex differences, positron emission tomography, hippocampus, basal ganglia, limbic system, sex hormones, receptor binding
MeSH terms: Adolescent, Adult, Aged, Aging, Brain, Brain Chemistry, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Pyridines, Reference Values, Sex Characteristics, Radiopharmaceuticals, Area Under Curve, Receptor, Cannabinoid, CB1, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks